REFERENCES
- Carter O., MacCarter D., Mannebach S., et al. D-Ribose improves peak exercise capacity and ventilatory efficiency in heart failure patients. Journal of the American College of Cardiology 2005; 45(3 Suppl. A)185A
- Gross M., Reiter S., Zollner N. Metabolism of D-ribose administered to healthy persons and to patients with myoadenylate deaminase deficiency. Klinische Wochenschrift 1989; 67: 1205–1213, Doi: 1007/BF01716208
- Ingwall J. S. ATP and the Heart. Kluwer, Boston, MA 2002
- Omran H., Illien S., MacCarter D., et al. D-Ribose improves diastolic function and quality of life in congestive heart failure patients: A prospective feasibility study. European Journal of Heart Failure 2003; 5: 615–619, Doi: 10.1016/S1388-9842(03)00060-6
- Pauly D., Pepine C. D-Ribose as a supplement for cardiac energy metabolism. Journal of Cardiovascular Pharmacology and Therapeutics 2000; 5(4)249–258
- Perkowski D., Wagner S., Marcus A., et al. Pre-surgical loading of oral d-ribose improves cardiac index in patients undergoing “off pump” coronary artery revascularization. The FASEB Journal 2005; 19: A695, (4 Pt.1)
- Pliml W., von Arnim T., Stablein A., et al. Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. The Lancet 1992; 340: 507–510, Doi: 10-1016/0140-6736(92)91709-H
- Segal S., Foley J. The metabolism of D-ribose in man. Journal of Clinical Investigation 1958; 37: 719–735
- Vijay N., MacCarter D., Washam M., et al. Ventilatory efficiency improves with d-ribose in congestive Heart Failure patients. Journal of Molecular and Cellular Cardiology 2005; 38(5)820
- Zimmer H. G. Regulation of and intervention into the oxidative pentose phosphate pathway and adenine nucleotide metabolism in the heart. Molecular and Cellular Biochemistry 1996; 160–161; 101–109, Doi: 10.1007/BF00240038